Company / Cash per Share
Arcutis Biotherapeutics, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.36
FY2025
5-year range
$0.36 / $1.95
FY2021-FY2025
Trend
-50.6%
vs FY2024
Sector context
#184 of 205
Health Care
What the data says
Among 205 Health Care companies, Arcutis Biotherapeutics, Inc. is in the bottom 10% for cash per share. Cash per Share has fluctuated over the past 7 years, ranging from $0.36 in FY2025 to $34.36 in FY2019.
Based on SEC 10-K filings.
0.36 in FY2025 with a 5-year CAGR of -27.6%.
Declined from $1.28 to $0.36 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -28.0%
- 5-Year CAGR
- -27.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 205This company $0.36 Sector average $67.98
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 50.6% year-over-year.
- Ranks #184 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.36 | -50.6% |
| FY2024 | $0.74 | -42.2% |
| FY2023 | $1.28 | +30.9% |
| FY2022 | $0.97 | -50.1% |
| FY2021 | $1.95 | +7.0% |
| FY2020 | $1.82 | -94.7% |
| FY2019 | $34.36 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026